TCL Archive FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds December 26, 2003
TCL Archive In Brief: Weicker Joins Tobacco Company Board; Hatfield To Leave Senate Next Year December 8, 1995
TCL Archive DRG Reimbursement Schedules Estimated for High, Low Areas; City Of Hope Added to Exemptions, Other Without Much Hope November 18, 1983
TCL Archive Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products. July 9, 2004